Point72 (DIFC)’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-740
Closed -$27.1K 1545
2025
Q1
$27.1K Buy
+740
New +$25.5K ﹤0.01% 1305
2024
Q4
Sell
-2,639
Closed -$99.4K 1507
2024
Q3
$99.4K Buy
2,639
+2,151
+441% +$82.9K ﹤0.01% 978
2024
Q2
$19.3K Buy
+488
New +$15.8K ﹤0.01% 1241

Other funds holding ATEX

Point72 (DIFC)'s ATEX Position: Q2 2025 in Review

Point72 (DIFC) sold out of Anterix (ATEX) in Q2 2025, closing a stake of 740 shares — an estimated $27.1K sold.

Point72 (DIFC) first reported a position in ATEX in Q2 2024 and held it in 3 quarters. The position peaked at $99.4K in Q3 2024. 111 funds tracked by Wall St. Rank hold ATEX as of Q2 2025.

  • Point72 (DIFC) reported no remaining Anterix position as of Q2 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 740 Anterix shares in Q2 2025, an estimated $27.1K.
  • Point72 (DIFC) first reported a position in Anterix in Q2 2024 and held it in 3 quarters.
  • Point72 (DIFC)'s Anterix position peaked at $99.4K in Q3 2024.
  • 111 funds tracked by Wall St. Rank held Anterix as of Q2 2025.

Based on Point72 (DIFC)'s 13F filing for Q2 2025, filed 14 Aug 2025.